Dr. Reddy's acquires Jet Generici Srl. Acquisition to establish Generics business in Italy
- Details
- Category: Business
Dr. Reddy's Laboratories Ltd (NYSE:RDY) announced that it has acquired Jet Generici Srl, a company engaged in the sale of generic finished dosages in Italy. The deal has been completed via Dr Reddy's Italian subsidiary, Reddy Pharma Italia SpA, which has been engaged in building a pipeline of registrations since its incorporation.
Novartis to first acquire 25% stake from Nestlé for USD 143.18 per share for USD 11 billion
- Details
- Category: Novartis
Novartis has reached an agreement with Nestlé S.A. providing the right to acquire majority ownership of Alcon Inc. (NYSE: ACL) in two steps and add the world leader in eye care to its diversified portfolio focused on growth areas of healthcare.
The first vaccine licensed to complete the rotavirus immunisation series by four months of age
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. Rotarix will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age.
International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM)
- Details
- Category: Abbott
Clinical laboratory professionals worldwide are coming together in support of an initiative to raise international awareness of the role played by clinical laboratory professionals in health care and their vital contribution to improve patient outcomes. Through a program called Labs Are Vital(TM), sponsored by Abbott (NYSE: ABT), the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and its 76 national societies are working together to elevate the role of laboratory professionals and to address issues facing the profession globally.
Lipitor Provided an Unexpectedly Potent Heart Benefit
- Details
- Category: Pfizer
Pfizer announced that Lipitor® (atorvastatin calcium) 80 mg showed unexpectedly potent reduction in myocardial ischemia (a condition defined by insufficient blood supply and oxygen to the heart) in patients with chronic stable angina (chest pain). These results were presented at the annual meeting of the American College of Cardiology.
Pfizer Successfully Completes Tender Offer for Shares of Encysive Pharmaceuticals Inc.
- Details
- Category: Pfizer
Pfizer Inc (NYSE:PFE) announced that Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer, has purchased all of the shares validly tendered and not withdrawn pursuant to its tender offer for all of the outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ: ENCY) at a purchase price of $2.35 per share, net to the seller in cash, without interest thereon and less any required withholding taxes.
Rasilez® reduces left ventricular hypertrophy, a powerful predictor of heart disease
- Details
- Category: Novartis
Rasilez® (aliskiren), the first-in-class direct renin inhibitor, has shown clinically meaningful reductions in left ventricular hypertrophy, a proven predictor of heart disease, that are comparable to those seen with the current standard-of-care treatment[1].
More Pharma News ...
- Bayer appeals invalidity ruling on its Yasmin® Patent
- Crestor Outcomes Study JUPITER Closes Early Due To Unequivocal Evidence Of Benefit
- Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission
- Levitra® - Therapy suitable for men with High Cholesterol
- Aurobindo Pharma expands in Europe
- GSK charitable support valued at £282 million in 2007
- Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent